Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006.

International journal of clinical pharmacology and therapeutics

Volumn 41, Issue 12, 2003, Pages 616-617

  Heim, M ^a   Sharifi, M ^a   Hilger, R A ^a   Scheulen, M E ^a   Seeber, S ^a   Strumberg, D ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; PYRIDINE DERIVATIVE; RAF PROTEIN; SORAFENIB;

ARTICLE; CARCINOMA; CELL CULTURE; CELL CYCLE; COLON TUMOR; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; PATHOLOGY;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZENESULFONATES; CARCINOMA; CELL CYCLE; COLONIC NEOPLASMS; HUMANS; PROTO-ONCOGENE PROTEINS C-RAF; PYRIDINES; TUMOR CELLS, CULTURED;

EID: 1542752272     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP41616     Document Type: Article

References (0)